Poster, Podium & Video Sessions
Presentation Authors: Emanuele Rubilotta, Matteo Balzarro*, Silvia Bassi, Paolo Corsi, Marco Pirozzi, Trabacchin Nicolò, Antonio Benito Porcaro, Antonio D'Amico, Walter Artibani, Verona, Italy
Introduction: Aim of our study was to evaluate the prevalence of 'pure' SUI (P-SUI), in a cohort underwent urodynamic test (UD) for urinary incontinence (UI), and the correspondence with UD findings. We also estimated the amount of costs of UD, and if the UD data could change the surgical indications.
Methods: We did a retrospective evaluation of the UD-database selecting 544 women with UI between January 2012 and July 2016. Pure SUI was defined by the International Continence Society criteria (table 1). Two very experienced urologists evaluated data.
Data researched were:
- Prevalence of clinical and UD P-SUI
- Correspondence between clinical P-SUI and UD findings
- Accurate estimation in € of a single UD examination, including the human resources and materials used
- Total amount of UD costs in € in P-SUI patients
- Number of surgical procedures avoided due to UD results
- Related avoided surgical costs in € in P-SUI patients
Results: SUI was present in 323/544 (59.4%), in this group the prevalence of P-SUI was 20.7% (67/323) while the prevalence of complicated SUI was 79.3% (256/323).
The correspondence between the clinical diagnosis of P-SUI and the UD findings was 88% (59/67 patients). For this reason after UD the number of patients with diagnosis of P-SUI decreased to 59/323 with a rate of 18.3%.
The cost of each UD study was 383 € and the total amount for this cohort of patients was 25.661 €. As consequence of a change of the therapeutic treatment after UD findings we did not performed the scheduled middle urethral sling in 6 patients with a total amount saved of 10.800 €.
Conclusions: UD study detected a relevant prevalence of P-SUI as 1/5 of the amount of the SUI women. The correspondence between clinical and UD findings was high. A total amount cost of P-SUI patients is not negligible respect to the total UD budget. Nevertheless, UD was able to avoid an inappropriate procedure in 9% of the patients.
Source Of Funding: None
A.O.U.I. Verona, Italy
Assistant Professor, and staff member in dept. of Urology, Azienda Ospedaliera Universitaria Integrata di Verona (AOUI), Verona, Italy (since 2010).
Second level master’s degree on risk management and patient safety (2016).
Head of the female urology section in the Dept. of Urology, AOUI Verona, Italy since 2013.
Staff member and head of the female urology section in the Dept of Urology, Ospedale Civile Maggiore, Verona, Italy (2002-2009).
5°th ESU Masterclass on Female & Functional Reconstructive Urology in Berlin (2012).
Post-doctoral fellow in female urology at the Scott Department of Urology at Baylor College of Medicine in 2001 (Houston, TX, USA).
Research fellow on female urology at Cleveland Clinic in 2000 (Cleveland, Oh, USA).
Urology fellowship in Verona, Italy.
Medical School of Università degli Studi di Verona (Verona, Italy) since august 1997 when he graduated with full marks.
• Member EAU (European Association of Urology)
• Associate member of ESFFU (European Section of Female and Functional Urology) of EAU
• Member IUGA (International UroGynecology Association)
• Member editing IUGA (International UroGynecology Association)
• Member ICS (International Continence Society)
• Member SIUD (Società Italiana di UroDinamica)
• Member SIU (Società Italiana di Urologia)
Sunday, May 14
3:30 PM – 5:30 PM